Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00080158 · ClinicalTrials.gov registry record · Phase 2
Treatment of Adolescent Suicide Attempters (TASA)
A Phase 2 study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
NCT00080158 is a Phase 2 study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 120 participants.
The verdict
NCT00080158, a Phase 2 study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effects of three types of treatments for depressed teenagers who have attempted suicide.
Interventions
- DRUG sertraline
- DRUG escitalopram
- DRUG bupropion
- DRUG fluoxetine
- DRUG citalopram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2004-03 |
| Est. Completion | 2007-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00080158
The ClinicalTrials.gov registry entry for NCT00080158 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which sertraline is the first listed.
NCT00080158 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00080158 about?
NCT00080158 is a clinical study titled "Treatment of Adolescent Suicide Attempters (TASA)". The purpose of this study is to compare the effects of three types of treatments for depressed teenagers who have attempted suicide.
What is the current status of trial NCT00080158?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2004-03. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00080158?
The interventions under investigation include: sertraline (DRUG), escitalopram (DRUG), bupropion (DRUG), fluoxetine (DRUG), citalopram (DRUG).
Who is sponsoring clinical trial NCT00080158?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.